2021
DOI: 10.1126/scitranslmed.abg2344
|View full text |Cite
|
Sign up to set email alerts
|

Functional human IgA targets a conserved site on malaria sporozoites

Abstract: Immunoglobulin (Ig)A antibodies play a critical role in protection against mucosal pathogens. However, the role of serum IgA in immunity to nonmucosal pathogens, such as Plasmodium falciparum, is poorly characterized, despite being the second most abundant isotype in blood after IgG. Here, we investigated the circulating IgA response in humans to P. falciparum sporozoites that are injected into the skin by mosquitoes and migrate to the liver via the bloodstream to initiate malaria infection. We found that circ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
21
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 24 publications
(23 citation statements)
references
References 69 publications
(111 reference statements)
2
21
0
Order By: Relevance
“…Mass spectrometry or microarrays can be used to identify mAb targets, while their functionality will have to be tested with hepatic cell lines and in in vivo models. The identified mAbs may further support structure-based vaccine identification, design, and clinical development as previously shown for CSP and RH5 vaccines ( 34 , 35 ).…”
Section: Discussionsupporting
confidence: 62%
“…Mass spectrometry or microarrays can be used to identify mAb targets, while their functionality will have to be tested with hepatic cell lines and in in vivo models. The identified mAbs may further support structure-based vaccine identification, design, and clinical development as previously shown for CSP and RH5 vaccines ( 34 , 35 ).…”
Section: Discussionsupporting
confidence: 62%
“…Since the SPZ binding of repeat mAbs is antagonized by other repeat mAbs (Fig 6B -6D) but not N-or C-CSP mAbs (Figs 5C and 6E and S4B), we next determined how a polyclonal PfCSP antibody response would affect the SPZ binding of repeat mAbs. The Pb-PfCSP-SPZ binding of A750-labeled CIS43, L9, or 317 were assessed in the presence of serum pooled from ten naïve mice immunized three times with R21 (virus-like particles composed of 19 NANP repeats and C-CSP fused to a single hepatitis B surface antigen [39]), fifteen naïve US adults immunized three times with irradiated PfSPZ [51], and ten children or adults with the highest FL-rCSP titers from a cohort of 758 Malian volunteers naturally exposed to malaria [52]. Serum from a malaria-naïve US adult was included as a negative control.…”
Section: Combining R21 Vaccination and Passive Repeat Mab Administration Increases Protectionmentioning
confidence: 99%
“…Clinical specimens (i.e., peripheral blood mononuclear cells and serum) were derived from malaria-naïve, healthy adults in the VRC 314 clinical trial (https://clinicaltrials.gov/; NCT02015091), a multi-institution, phase 1, open-label, dose-escalation trial with controlled human malaria infection designed to assess the safety, immunogenicity, and protective efficacy of the Sanaria PfSPZ Vaccine administered by intravenous or intramuscular injection [51]. Serum was also collected from a cohort study conducted in the rural village of Kalifabougou, Mali [52,58].…”
Section: Human Clinical Specimensmentioning
confidence: 99%
“…CD21/CD27 staining (bottom panels) within total (left) and Pf + (right) CD10 -IgD -B cells, with gating to identify actBCs, MBCs and atBCs. (B) Percentages of atBCs, MBCs and actBCs within the total, Pf + and HA + IgD -CD10 -B cell populations in children(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17) years; n=34) at baseline (filled circles) and 7 days after febrile malaria (empty squares), Malian adults (n=20) and malaria-naïve U.S. adults (n=15) at their baseline. Each dot indicates an individual, connected lines show paired samples, bars show means.…”
mentioning
confidence: 99%